Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. - Wikidata - wikimedia - TriplyDB

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

http://www.wikidata.org/entity/Q33857479

about

Breaking the Spell: Combating Multidrug Resistant 'Superbugs'Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy Single amino acid substitution in homogentisate 1,2-dioxygenase is responsible for pigmentation in a subset of Burkholderia cepacia complex isolates Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics.Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor.Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes.Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.Obesity and the gut microbiome: Striving for causality.Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo.Burkholderia cepacia septicemia in a patient with acute myeloid leukemia in postchemotherapy bone marrow aplasia.Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.Totally drug-resistant tuberculosis and adjunct therapies.Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics.Evaluation of the electron transfer flavoprotein (ETF) as an antibacterial target in Burkholderia cenocepacia.17β-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism.Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation.(Non-)translational medicine: targeting bacterial RNA Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa.Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function.Inhibition of Bacterial Growth by Peptide-Conjugated Morpholino Oligomers.Advances in therapeutic bacterial antisense biotechnology.Aggregation and Disaggregation of Morpholino Oligomers in Solution.Peptide-conjugated phosphorodiamidate morpholino oligomers: a new strategy for tackling antibiotic resistance.Emerging drugs and drug targets against tuberculosis.Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex

P2860

Q26765868-A8CDA01B-012E-4C88-9C85-1B68915C57A2 Q28554197-874BBE1B-84B7-4015-92C1-5172AF872272 Q30303140-66114B9B-3603-49DE-BCFD-B286D4543B8A Q30425441-A1EED617-2C67-46C6-AE3B-8BF9AF267479 Q34417003-41676615-239E-45C6-BB12-7372AC59932C Q34489893-03C1DF36-21E8-4E48-8298-B422C3FB1FEF Q34873275-50F63653-FA1E-40FB-B436-ED07C439D01D Q35105919-7EE9A673-E403-4BC4-8CBF-3F04630F4237 Q35289367-934F79F8-B8EA-49A8-9A18-52CA03195A4F Q35805503-6D37201B-7DE9-4218-88AC-8BF84517996C Q36297919-CE78130F-5413-4B3E-8BCB-B0E5C9746A81 Q36432717-38BA37C2-F378-4AB2-BE0E-0D933CD0F7EE Q37133415-0ED18917-7CFE-40B3-9B3C-25920D4810A7 Q37247490-09273553-3AAF-4539-9427-78A8F8FBDE14 Q37382615-B3CD3F79-7117-4E7D-979D-2A8E74E66EFB Q37876027-900C6249-569D-41B7-8558-06674D21A0F2 Q38210265-F69D036D-D646-480B-8C69-09E2293916C4 Q38289742-EE16DD94-0669-40EB-B41F-660DF009409D Q38991210-89660917-56FC-4404-A36D-3E9D94107A0B Q39080538-1DF4A23B-1C92-43CF-A562-37202F78277B Q39301644-686AFCE5-F3F7-4860-AE6D-7000BBA478D6 Q39379540-45634F63-AF66-44C0-B4B5-BC5B1EF410AB Q39414836-3D97DA7F-1799-41EB-8E8E-627C8E4714E1 Q40089786-252AEA8B-FD51-4058-AB38-4CE974473A5A Q40103064-A0035894-9B84-43CF-AAA1-DFD4AC976818 Q40157851-9A822F1A-E81B-4F6E-865F-8AE5A0D631D2 Q42276515-123CC35D-4985-4F1C-B64F-645342678DB6 Q42522615-B327F2B1-0FD0-401D-A0BE-4DAB0DAA5A3D Q44933756-32165E48-BA7E-4CD7-9F88-008485018107 Q47137042-F2767018-ED6F-4F0A-94B0-49B0DC99B6B7 Q47325247-0D1F2A46-0652-449D-9366-4BBCF6C5926E Q50760058-6F10737C-37B7-4601-8165-801E81138DFE Q51750512-2923AD3B-983D-4B2F-BF81-AAD1556FF5B9 Q53746587-2FAAC724-31C2-4BE8-BF99-80C0C670965E Q58803724-FF0004E2-A9DF-41EA-A5F7-07EA511EF18C

P2860

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

http://www.wikidata.org/entity/Q33857479

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antisense phosphorodiamidate m ...... Burkholderia cepacia complex.

@ast

Antisense phosphorodiamidate m ...... Burkholderia cepacia complex.

@en

type

label

Antisense phosphorodiamidate m ...... Burkholderia cepacia complex.

@ast

Antisense phosphorodiamidate m ...... Burkholderia cepacia complex.

@en

prefLabel

Antisense phosphorodiamidate m ...... Burkholderia cepacia complex.

@ast

Antisense phosphorodiamidate m ...... Burkholderia cepacia complex.

@en

P1433

Q33857479-F9D78831-95C8-4018-AE41-4F2F533769AA

P1476

Q33857479-BA661B48-35D2-4F95-B4F1-45125D96EDA7

P2093

Q33857479-0309C38A-6F61-4FF4-A586-1D3352F0105B

Q33857479-12C673B1-3320-4D1A-970D-43B4073FAEFC

Q33857479-4D52337F-AB08-4BD4-A613-53F826F69541

Q33857479-68A6E878-BC1B-454B-A08C-25294D52FC6F

Q33857479-782EAF27-9C3D-45B1-A215-4FBF6E05F6C8

Q33857479-A5075EF0-6E39-4DCD-BFDC-DDBACC19A78D

Q33857479-E36F32CA-FEBA-487D-B8C1-03BFDA819358

P2860

Q33857479-0BA77551-A305-4A34-A80B-763C3A80D2B7

Q33857479-2028F286-F5A9-41D7-92D8-EA1B899DB512

Q33857479-24FCB509-FA35-41FB-81D4-767BEAD1D8E2

Q33857479-273DEB63-0510-4172-8518-FC470B8AB06A

Q33857479-2D6D7DBC-8EF3-40F7-B9BC-242B005FC73A

Q33857479-2EB5BC8D-9E6B-47D5-A252-50995F6DCB9D

Q33857479-3121593C-3882-45B6-92B1-BDF98B979DDF

Q33857479-3688E6E4-3C84-40AF-9392-39F4754206F8

Q33857479-3A7EAA1A-086A-44DE-9A7D-F84BC87E8AF9

Q33857479-3F8876C1-2957-4D95-9DD1-7D0E7548DEEF

P304

Q33857479-6BAE8478-3AEE-4BDF-9D1E-E135678C0D09

P31

Q33857479-A38A3F6F-F78A-4B9A-BE27-C54DF054A1DD

P356

Q33857479-C24940E1-55EC-4132-ADA0-2455A99EB9BA

P407

Q33857479-AA556689-71E5-4BBE-A2CE-720ADC2027F9

P433

Q33857479-5C4B0AB3-DE0D-4A8E-8F9B-668770EF7438

P478

Q33857479-DC93502A-781E-40C9-962C-030DF76E5A0E

P50

Q33857479-A7D6248A-88A2-40F7-AB25-AC0D2CF485BF

Q33857479-BA733B5F-5773-42F1-B466-7C2432BD8EB3

P577

Q33857479-534280BD-B451-455E-84F5-B1437A66E375

P5875

Q33857479-3ACC4822-BE91-479B-B9B7-F159B8C1FDC7

P698

Q33857479-9DB3F385-0772-4E0D-AFE2-55CC2F27B462

P932

Q33857479-E70FD7E6-1E29-4D61-B72B-F638B660B81D

P356

P1433

The Journal of Infectious Diseases

P1476

Antisense phosphorodiamidate m ...... t Burkholderia cepacia complex

@en

P2093

Brett L Mellbye

http://www.w3.org/2001/XMLSchema#string

Bruce L Geller

http://www.w3.org/2001/XMLSchema#string

David E Greenberg

http://www.w3.org/2001/XMLSchema#string

Kimberly R Marshall-Batty

http://www.w3.org/2001/XMLSchema#string

Lauren R Brinster

http://www.w3.org/2001/XMLSchema#string

Pamela A Shaw

http://www.w3.org/2001/XMLSchema#string

Steven M Holland

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus

Update on the Burkholderia cepacia complex

The multifarious, multireplicon Burkholderia cepacia complex

An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants

Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center.

Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease.

Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex.

P304

1822-1830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/652807

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

Patrick L Iversen

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44569328

http://www.w3.org/2001/XMLSchema#string

P698

20438352

http://www.w3.org/2001/XMLSchema#string

P932

2872041

http://www.w3.org/2001/XMLSchema#string